|
Endo Pharmaceuticals wants the pain to end, preferably through the drugs it acquires and markets. The pharmaceutical company has a portfolio of both branded and generic prescription products for pain management. Its best-selling drug is Lidoderm, a lidocaine patch that treats nerve pain caused by shingles; it accounts for about two-thirds of the company's revenue. Endo also sells well-known pain meds Percodan and Percocet, as well as migraine therapy Frova. Its generics include morphine and oxycodone tablets. The company markets its drugs in the US through its own domestic sales force; however, it outsources almost everything else, from manufacturing to distribution to clinical development acitivities.
|
| | | Contact Information | |
Address: |
100 Endo Blvd.
Chadds Ford, PA 19317
| | Phone: | 610-558-9800 | | Fax: | 610-558-8979 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 1260.50 M | | Revenue Growth (1 yr): | 16.10% | | Employees (2008): | 1,216 | | Employee Growth (1 yr): | 0.70% |
|
|
Key People
| | • |
Chairman:
Roger H. Kimmel
| | • |
President, CEO, and Director; President and CEO, Endo Pharma:
David P. Holveck
| | • |
EVP and CFO:
Alan G. Levin
|
|
|
